ArticleTrials2023

Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol.

Maohui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.